We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $8.15B
1-Year Est. Return 20.12%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+20.12%
3 Year Est. Return
+59.68%
5 Year Est. Return
+57.89%
10 Year Est. Return
+205.42%
AUM
$6.96B
AUM Growth
+$142M
Cap. Flow
+$52M
Cap. Flow %
0.75%
Top 10 Hldgs %
30.63%
Holding
1,777
New
149
Increased
575
Reduced
805
Closed
168

Sector Composition

Rank Sector Weight
1 Technology 12.73%
2 Financials 8.51%
3 Consumer Discretionary 4.88%
4 Healthcare 3.88%
5 Industrials 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
76
AbbVie
ABBV
$458B
$18.4M 0.26%
103,894
+20,938
+25% +$3.85M
EFG icon
77
iShares MSCI EAFE Growth ETF
EFG
$16.3B
$17.9M 0.26%
185,293
+114,155
+160% +$11.6M
XOM icon
78
ExxonMobil
XOM
$651B
$17.9M 0.26%
168,423
-83,041
-33% -$9.71M
KO icon
79
Coca-Cola
KO
$354B
$17.8M 0.26%
287,124
+92,041
+47% +$6.01M
JPST icon
80
JPMorgan Ultra-Short Income ETF
JPST
$40B
$17.4M 0.25%
344,256
+292,546
+566% +$14.8M
MCD icon
81
McDonald's
MCD
$188B
$16.8M 0.24%
58,128
+17,743
+44% +$5.29M
ADP icon
82
Automatic Data Processing
ADP
$100B
$16.8M 0.24%
57,312
+10,760
+23% +$3.18M
ORCL icon
83
Oracle
ORCL
$331B
$16.8M 0.24%
100,669
+5,598
+6% +$994K
WMT icon
84
Walmart Inc
WMT
$871B
$16.5M 0.24%
181,913
+732
+0.4% +$63.5K
IGSB icon
85
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$16.2M 0.23%
+314,034
New +$16.3M
VO icon
86
Vanguard Mid-Cap ETF
VO
$106B
$16.1M 0.23%
244,344
+10,608
+5% +$720K
PM icon
87
Philip Morris
PM
$301B
$15.7M 0.23%
130,873
+79,959
+157% +$10.1M
CRM icon
88
Salesforce
CRM
$134B
$15.5M 0.22%
46,336
-1,595
-3% -$509K
IXUS icon
89
iShares Core MSCI Total International Stock ETF
IXUS
$57.5B
$15.2M 0.22%
229,787
-22,347
-9% -$1.55M
BSV icon
90
Vanguard Short-Term Bond ETF
BSV
$44.6B
$15.1M 0.22%
195,006
+114,845
+143% +$8.91M
PEP icon
91
PepsiCo
PEP
$186B
$14M 0.2%
91,725
+23,158
+34% +$3.79M
ITOT icon
92
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
$14M 0.2%
108,569
-9,337
-8% -$1.21M
MRK icon
93
Merck
MRK
$324B
$13.7M 0.2%
137,690
+22,112
+19% +$2.28M
MA icon
94
Mastercard
MA
$477B
$13.7M 0.2%
25,980
-374
-1% -$194K
ABT icon
95
Abbott
ABT
$180B
$13.4M 0.19%
118,585
+26,606
+29% +$3.07M
GVI icon
96
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
$12.8M 0.18%
+122,920
New +$12.9M
EEM icon
97
iShares MSCI Emerging Markets ETF
EEM
$28B
$12.7M 0.18%
304,356
-15,558
-5% -$689K
RTX icon
98
RTX Corp
RTX
$287B
$12.5M 0.18%
108,496
-993
-0.9% -$120K
VCSH icon
99
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$12.5M 0.18%
160,194
+83,003
+108% +$6.51M
DIS icon
100
Walt Disney
DIS
$165B
$12.4M 0.18%
111,349
+25,937
+30% +$2.72M

Similar funds

Choreo LLC's Q4 2024 Portfolio in Review

As of Q4 2024, Choreo LLC held 1,777 positions worth $6.96B, up 2.1% from $6.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Choreo LLC's Q4 2024 filing shows 149 new, 575 increased, 805 reduced and 168 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 314,034 shares worth $16.2M. The largest sale was MACOM Technology Solutions, an estimated $64.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Choreo LLC's largest Q4 2024 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 314,034 shares worth $16.2M.
  • Choreo LLC added most to iShares Russell 1000 Growth ETF in Q4 2024, an estimated $68.8M increase.
  • Choreo LLC's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $41.5M.
  • Choreo LLC fully exited MACOM Technology Solutions in Q4 2024, selling an estimated $64.2M.
  • Choreo LLC's ten largest holdings make up 31% of its $6.96B portfolio in Q4 2024.
  • Choreo LLC opened 149 new positions and closed 168 in Q4 2024.
  • Choreo LLC's portfolio value rose 2.1% quarter-over-quarter to $6.96B.

Based on Choreo LLC's 13F filing for Q4 2024, filed 27 Jan 2025.